<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>08436566761222</udiDi>
    <basicUdiDi>B-08436566761222</basicUdiDi>
    <tradeName>NIPT-GeneSGKit CE-IVD 48 Reacciones</tradeName>
    <deviceName>NIPT-GeneSGKit CE-IVD 48 Reacciones</deviceName>
    <manufacturerName>SISTEMAS GENOMICOS. S.L.</manufacturerName>
    <manufacturerSrn>ES-MF-000022949</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W0106010399</emdnCode>
    <emdnDescription>CHROMOSOMAL DISORDERS TESTS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>LV3737</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-07-07T21:43:19.997Z</lastUpdated>
  </row>
  <row>
    <udiDi>08057723370615</udiDi>
    <basicUdiDi>B-08057723370615</basicUdiDi>
    <tradeName>08057723370615</tradeName>
    <deviceName>SMART SNP MTHFR 1298 Positive Control</deviceName>
    <manufacturerName>BIOCLARMA S.R.L.</manufacturerName>
    <manufacturerSrn>IT-MF-000030384</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W0106010199</emdnCode>
    <emdnDescription>MONOGENETIC DISORDERS TESTS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>SNPD-032 CTRL</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-07-07T18:37:31.848Z</lastUpdated>
  </row>
  <row>
    <udiDi>08057723370608</udiDi>
    <basicUdiDi>B-08057723370608</basicUdiDi>
    <tradeName>08057723370608</tradeName>
    <deviceName>SMART SNP Coagulation Factors POSITIVE CONTROL</deviceName>
    <manufacturerName>BIOCLARMA S.R.L.</manufacturerName>
    <manufacturerSrn>IT-MF-000030384</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W0106010199</emdnCode>
    <emdnDescription>MONOGENETIC DISORDERS TESTS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>SNPD-CF CTRL</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-07-07T18:37:31.032Z</lastUpdated>
  </row>
  <row>
    <udiDi>08057723370110</udiDi>
    <basicUdiDi>B-08057723370110</basicUdiDi>
    <tradeName>08057723370110</tradeName>
    <deviceName>SMART SNP FII FVL Direct Kit</deviceName>
    <manufacturerName>BIOCLARMA S.R.L.</manufacturerName>
    <manufacturerSrn>IT-MF-000030384</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W0106010115</emdnCode>
    <emdnDescription>COMBINED FACTOR II / FACTOR V LEIDEN</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>SNPD-034</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-07-07T18:35:54.927Z</lastUpdated>
  </row>
  <row>
    <udiDi>08057723370103</udiDi>
    <basicUdiDi>B-08057723370103</basicUdiDi>
    <tradeName>08057723370103</tradeName>
    <deviceName>SMART SNP MTHFR 677 Direct Kit</deviceName>
    <manufacturerName>BIOCLARMA S.R.L.</manufacturerName>
    <manufacturerSrn>IT-MF-000030384</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W0106010199</emdnCode>
    <emdnDescription>MONOGENETIC DISORDERS TESTS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>SNPD-033</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-07-07T18:35:54.255Z</lastUpdated>
  </row>
  <row>
    <udiDi>08057723370097</udiDi>
    <basicUdiDi>B-08057723370097</basicUdiDi>
    <tradeName>08057723370097</tradeName>
    <deviceName>SMART SNP MTHFR 1298 Direct Kit</deviceName>
    <manufacturerName>BIOCLARMA S.R.L.</manufacturerName>
    <manufacturerSrn>IT-MF-000030384</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W0106010199</emdnCode>
    <emdnDescription>MONOGENETIC DISORDERS TESTS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>SNPD-032</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-07-07T18:35:53.309Z</lastUpdated>
  </row>
  <row>
    <udiDi>08057723370080</udiDi>
    <basicUdiDi>B-08057723370080</basicUdiDi>
    <tradeName>08057723370080</tradeName>
    <deviceName>SMART SNP FVL Direct Kit</deviceName>
    <manufacturerName>BIOCLARMA S.R.L.</manufacturerName>
    <manufacturerSrn>IT-MF-000030384</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W0106010103</emdnCode>
    <emdnDescription>FACTOR V LEIDEN</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>SNPD-030</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-07-07T18:35:48.512Z</lastUpdated>
  </row>
  <row>
    <udiDi>08057723370073</udiDi>
    <basicUdiDi>B-08057723370073</basicUdiDi>
    <tradeName>08057723370073</tradeName>
    <deviceName>SMART SNP FII Direct Kit</deviceName>
    <manufacturerName>BIOCLARMA S.R.L.</manufacturerName>
    <manufacturerSrn>IT-MF-000030384</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W0106010114</emdnCode>
    <emdnDescription>PROTHROMBIN MUTATION</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>SNPD-029</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-07-07T18:35:47.711Z</lastUpdated>
  </row>
  <row>
    <udiDi>08057680910695</udiDi>
    <basicUdiDi>B-08057680910695</basicUdiDi>
    <tradeName>Gluten DQuick DResolution</tradeName>
    <deviceName>Gluten DQuick DResolution</deviceName>
    <manufacturerName>Clonit srl</manufacturerName>
    <manufacturerSrn>IT-MF-000022196</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Ek II Liste B</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W0106010401</emdnCode>
    <emdnDescription>HLA-TYPING</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>RT-59v3_96</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-07-07T18:35:20.492Z</lastUpdated>
  </row>
  <row>
    <udiDi>08057680910688</udiDi>
    <basicUdiDi>B-08057680910688</basicUdiDi>
    <tradeName>Gluten DQuick Dresolution</tradeName>
    <deviceName>Gluten DQuick DResolution</deviceName>
    <manufacturerName>Clonit srl</manufacturerName>
    <manufacturerSrn>IT-MF-000022196</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Ek II Liste B</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W0106010401</emdnCode>
    <emdnDescription>HLA-TYPING</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>RT-59v3</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-07-07T18:35:19.706Z</lastUpdated>
  </row>
  <row>
    <udiDi>08057680910442</udiDi>
    <basicUdiDi>B-08057680910442</basicUdiDi>
    <tradeName>Duplicα Real Time HLA-B*5701 EZ Type Kit</tradeName>
    <deviceName>Duplicα Real Time HLA-B*5701 EZ Type Kit</deviceName>
    <manufacturerName>Clonit srl</manufacturerName>
    <manufacturerSrn>IT-MF-000022196</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Ek II Liste B</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W0106010401</emdnCode>
    <emdnDescription>HLA-TYPING</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>EER052032</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-07-07T18:33:29.303Z</lastUpdated>
  </row>
  <row>
    <udiDi>08057680910329</udiDi>
    <basicUdiDi>B-08057680910329</basicUdiDi>
    <tradeName>HLA-B27</tradeName>
    <deviceName>HLA-B27</deviceName>
    <manufacturerName>Clonit srl</manufacturerName>
    <manufacturerSrn>IT-MF-000022196</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Ek II Liste B</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W0106010401</emdnCode>
    <emdnDescription>HLA-TYPING</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>RT-53</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-07-07T18:33:28.500Z</lastUpdated>
  </row>
  <row>
    <udiDi>08720211480270</udiDi>
    <basicUdiDi>872021148P0155H</basicUdiDi>
    <tradeName>SALSA MLPA Probemix P015 MECP2</tradeName>
    <deviceName></deviceName>
    <manufacturerName>MRC Holland B.V.</manufacturerName>
    <manufacturerSrn>NL-MF-000000437</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W0106010199</emdnCode>
    <emdnDescription>MONOGENETIC DISORDERS TESTS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>P015-100R</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-07T12:44:23.783Z</lastUpdated>
  </row>
  <row>
    <udiDi>08033629920321</udiDi>
    <basicUdiDi>B-08033629920321</basicUdiDi>
    <tradeName>08033629920321</tradeName>
    <deviceName>Cystic Fibrosis</deviceName>
    <manufacturerName>Nuclear Laser Medicine srl</manufacturerName>
    <manufacturerSrn>IT-MF-000025709</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W0106010101</emdnCode>
    <emdnDescription>CYSTIC FIBROSIS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>AC023/25</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-07-07T09:14:16.242Z</lastUpdated>
  </row>
  <row>
    <udiDi>07350041434672</udiDi>
    <basicUdiDi>B-07350041434672</basicUdiDi>
    <tradeName>07350041434672</tradeName>
    <deviceName>ChromoQuant SuperSTaR Optima</deviceName>
    <manufacturerName>Cybergene AB</manufacturerName>
    <manufacturerSrn>SE-MF-000054343</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W0106010399</emdnCode>
    <emdnDescription>CHROMOSOMAL DISORDERS TESTS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>514.301-136</reference>
    <placedOnMarketCountry>Sweden</placedOnMarketCountry>
    <lastUpdated>2026-07-07T01:16:13.415Z</lastUpdated>
  </row>
  <row>
    <udiDi>07350041434665</udiDi>
    <basicUdiDi>B-07350041434665</basicUdiDi>
    <tradeName>07350041434665</tradeName>
    <deviceName>ChromoQuant SuperSTaR Optima</deviceName>
    <manufacturerName>Cybergene AB</manufacturerName>
    <manufacturerSrn>SE-MF-000054343</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W0106010399</emdnCode>
    <emdnDescription>CHROMOSOMAL DISORDERS TESTS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>514.301-68</reference>
    <placedOnMarketCountry>Sweden</placedOnMarketCountry>
    <lastUpdated>2026-07-07T01:16:11.801Z</lastUpdated>
  </row>
  <row>
    <udiDi>07350041434658</udiDi>
    <basicUdiDi>B-07350041434658</basicUdiDi>
    <tradeName>07350041434658</tradeName>
    <deviceName>ChromoQuant SuperSTaR Optima</deviceName>
    <manufacturerName>Cybergene AB</manufacturerName>
    <manufacturerSrn>SE-MF-000054343</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W0106010399</emdnCode>
    <emdnDescription>CHROMOSOMAL DISORDERS TESTS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>514.301-26</reference>
    <placedOnMarketCountry>Sweden</placedOnMarketCountry>
    <lastUpdated>2026-07-07T01:14:18.051Z</lastUpdated>
  </row>
  <row>
    <udiDi>07350041434641</udiDi>
    <basicUdiDi>B-07350041434641</basicUdiDi>
    <tradeName>ChromoQuant STaR Optima 2</tradeName>
    <deviceName>ChromoQuant STaR Optima 2</deviceName>
    <manufacturerName>Cybergene AB</manufacturerName>
    <manufacturerSrn>SE-MF-000054343</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W0106010399</emdnCode>
    <emdnDescription>CHROMOSOMAL DISORDERS TESTS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>514.201-26</reference>
    <placedOnMarketCountry>Sweden</placedOnMarketCountry>
    <lastUpdated>2026-07-07T01:14:17.261Z</lastUpdated>
  </row>
  <row>
    <udiDi>07350041434610</udiDi>
    <basicUdiDi>B-07350041434610</basicUdiDi>
    <tradeName>07350041434610</tradeName>
    <deviceName>ChromoQuant Optima XY</deviceName>
    <manufacturerName>Cybergene AB</manufacturerName>
    <manufacturerSrn>SE-MF-000054343</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W0106010306</emdnCode>
    <emdnDescription>MULTIPLE DETECTION OF CHROMOSOMAL DISORDERS TESTS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>514.604-26</reference>
    <placedOnMarketCountry>Sweden</placedOnMarketCountry>
    <lastUpdated>2026-07-07T01:14:16.442Z</lastUpdated>
  </row>
  <row>
    <udiDi>07350041434603</udiDi>
    <basicUdiDi>B-07350041434603</basicUdiDi>
    <tradeName>07350041434603</tradeName>
    <deviceName>ChromoQuant Optima 21</deviceName>
    <manufacturerName>Cybergene AB</manufacturerName>
    <manufacturerSrn>SE-MF-000054343</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W0106010301</emdnCode>
    <emdnDescription>DOWN'S SYNDROME</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>514.603-26</reference>
    <placedOnMarketCountry>Sweden</placedOnMarketCountry>
    <lastUpdated>2026-07-07T01:14:12.460Z</lastUpdated>
  </row>
</eudamedExport>